New combined biomarkers needed to be continuously discovered to improve the diagnostic effect of AFP, and the combination of AFP with ICAM-1 possesses high accuracy in both the early diagnosis and prognostic prediction of HCC and was expected to provide new credible indicators for the diagnosis of HCC. Here, ICAM1 is linked to hepatocellular carcinoma.